References
- Leurs P B, Mulder A W, Fiers H A, Hoorntje S J. Acute renal failure after cardiovascular surgery: current concepts in pathophysiology, prevention and treatment. Eur Heart J 1989; 10: 38–42
- Sieberth H G, Kierdorf H. Is continuous haemofiltration superior to intermittent dialysis and haemofiltration treatment?. Adv Exp Med Biol 1989; 260: 181–192
- Bogicevic M, Ilic S, Djordjevic V, Ivic M, Koracevic D, Stefanovic V. Thyroid hormone profiles in experimental acute renal failure. Renal Failure 1993; 15: 173–179
- Hronek I, Hronkova B, Davenport A, Mackenzie J C. Thyroid hormone levels in acute renal failure. Renal Failure 1993; 15: 47–49
- Ujiie K, Tomita K, Owada A, Matsui N, Marumo F. Angiotensin-converting enzyme activity as a prognostic factor in acute renal failure. Nephron 1991; 58: 443–449
- Sutter P M, Thulin G, Stromski M, Ardito T, Gaudio K M, Kashgarian M, Siegel N J. Beneficial effect of thyroxine in the treatment of ischemic acute renal failure. Pediatr Nephrol 1988; 2: 1–7
- Michael U F, Logan J L, Meeks L A. The beneficial effects of thyroxine on nephrotoxic acute renal failure in the rat. J Am Soc Nephrol 1991; 1: 1236–1240
- Nath K A, Paller M S. Dietary deficiency of antioxidants exacerbates ischemic injury in the rat kidney. Kidney Int 1990; 38: 1109–1117
- Baud L, Ardaillou R. Involvement of reactive oxygen species in kidney damage. Br Med Bull 1993; 49: 621–629
- Dubois F, Belleville F. Selenium: physiologic role and value in human pathology. Pathol Biol Paris 1988; 36: 1017–1025
- Corvilain B, Contempre B, Longombe A O, Goyens P, Gervy-Decoster C, Lamy F, Vanderpas J B, Dumont J E. Selenium and the thyroid: how the relationship was established. Am J Clin Nutr 1993; 57: 244S–248S
- Behne D, Kyriakopoulos A, Meinhold H, Kohrle J. Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme. Biochem Biophys Res Commun 1990; 173: 1143–1149
- Arthur J R, Nicol F, Hutchinson A R, Beckett G J. The effects of selenium depletion and repletion on the metabolism of thyroid hormones in the rat. J Inorg Biochem 1990; 39: 101–108
- Berry M J, Banu L, Larsen P R. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 1991; 349: 438–440
- Makropoulos W, Papadoiannakis G, Jakobi K, Schmutzler F, Einbrodt H J. Eine genaue und einfache Methode zur Selenbestimmung im Serum mittels Graphit-Atomabsorptionsspektrometrie. Wissenschaft und Umwelt, In press
- Arem R, Wiener G J, Kaplan S G, Kim H S, Reichlin S, Kaplan M M. Reduced tissue thyroid hormone levels in fatal illness. Metabolism 1993; 42: 1102–1108
- Kaptein E M, Robinson W J, Grieb D A, Nicoloff J T. Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. J Clin Invest 1982; 69: 526–535
- Cavalieri R R. The effects of nonthyroid disease and drugs on thyroid function tests. Med Clin North Am 1991; 75: 27–39
- Rabanal J M, Amado J A, Quesada A, Solares G, Diaz J, Vazquez A. Study of thyroid function in the organ donor during brain death. Rev Esp Anestesiol Reanim 1992; 39: 306–308
- Aaseth J, Frey H, Glattre E, Norheim G, Ringstad J, Thomassen Y. Selenium concentrations in the human thyroid gland. Biol Trace Elem Res 1990; 24: 147–152
- Berry M J, Kieffer J D, Harney J W, Larsen P R. Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase. J Biol Chem 1991; 266: 14155–14158
- Del-Boccio G, Casaccia R, Aceto A, Casalone E, De-Remigis P, Di-Ilio C. Glutathione metabolizing enzyme activities in human thyroid. Gen Pharmacol 1987; 18: 315–320